Storage Conditions
-20°C/1 year
Applications
ELISA
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. ELISA: 1/5000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
Synthesized peptide derived from the Internal region of human Tafazzin.
Subcellular Location
Intermembrane side .
Intermembrane side . Mitochondrion inner membrane
Mitochondrion outer membrane
Peripheral membrane protein
Peripheral membrane protein
[Isoform 1]: Mitochondrion membrane .
[Isoform 2]: Cytoplasm .
[Isoform 3]: Mitochondrion membrane .
[Isoform 5]: Mitochondrion membrane .
[Isoform 6]: Cytoplasm .
[Isoform 7]: Mitochondrion membrane .
[Isoform 8]: Cytoplasm .
[Isoform 9]: Cytoplasm .
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Human Gen
6901
Observed Band
33kD
Other Name
EFE2
G4.5
Protein G4.5
TAZ
Tafazzin
Background
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocard
the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [prov